Parent Project Muscular Dystrophy (PPMD) has granted $465,000 to Renzhi Han, PhD, a professor at the Ohio…
Articles by Catarina Silva, MSc
Nippon Shinyaku filed a request for the approval of viltolarsen (NS-065/NCNP-01) to treat Duchenne muscular dystrophy amenable to exon 53…
Sarepta Therapeutics is acquiring an investigational gene therapy program focused on calpain-3 for the treatment of limb-girdle muscular…
Long-term treatment with Raxone (idebenone) slows down loss of respiratory function in Duchenne muscular dystrophy (DMD) patients for up to…
Capricor Therapeutics announced that patient dosing has resumed in its HOPE-2 trial of CAP-1002, an investigative cell therapy…
Parent Project Muscular Dystrophy (PPMD) has granted $105,000 to the University of Missouri School of Medicine to advance research…
The University of Virginia (UVA) Children’s Hospital has been named a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), making…
On Saturday, coaches with the American Football Coaches Association (AFCA) across the U.S. will display patches to promote the annual…
Nonprofit Sing Me a Story and Numotion are collaborating to help children with various neuromuscular diseases served by the…
Nicholas Johnson, vice chair of research and associate professor of neurology…